Clinical Trial Update: Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

View source ↗

Summary

The trial update reports the effectiveness of dimethyl fumarate and its impact on patient-reported outcomes in suboptimal glatiramer acetate responders with rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Forms of Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing Forms of Multiple Sclerosis | Status: COMPLETED